Back to Quality Research
LDOSLeidos Holdings Inc
Industrials · Diversified Support Services · Large
$136.08+1.00%
As of 23 Oct 2026Mkt cap $16.8B
Stage 13
AVOID
Fundamentals
58.0/75
Technical
5.0/15
Independent
63.0/90
GCAE viewstructural technical damage is a hard non-actionable condition
Price
- 1M
- +10.3%
- 3M
- +18.4%
- 6M
- −6.8%
- 1Y
- −27.8%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 12.7xHist median 16.0x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 8.2x
- FCF yield
- 12.2%
Quality
- ROIC
- 20.0%
- Operating margin
- 11.0%
- FCF margin
- 9.5%
- Current ratio
- 1.7x
Growth
- Revenue growth
- +3.1%Latest FY YoY
- Revenue CAGR
- +5.7%
- EPS CAGR
- +20.6%
- FCF CAGR
- +15.0%
Capital
- Share-count trend
- −2.9%3Y annualised
- Net debt
- $3.5B2.0x OCF
Annual trend
- CAGR 2021–2025
- +5.7%
- Latest · 2025
- $17B
- YoY
- +3.1%
GCAE Research
- Quality Research
- REINFORCES
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- RECHECK BEFORE ACTION
Key takeaway
Fresh 24 October review found no material company-specific evidence sufficient to change the approved qualitative verdict; the stated watch items remain unresolved.
Unresolved question
Which timing read is better supported as new price and operating evidence arrives: production v2 or research v3?
Watch next
- ARTEMIS options and autonomy follow-on awards
- funded backlog conversion and LCST contract margins
- screening JV integration and cash distributions to Leidos
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- damaged
- Rotation
- headwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- CURRENT
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded